Cagrilintide + GLP-1S (10mg Blend)

Original price was: £199.99.Current price is: £169.99.

Research Studies:

  • Combo of cagrilintide (amylin analog) + GLP‑1S (GLP‑1R agonist) for multi‑target assays
  • Supports in vitro profiling of amylin and GLP‑1 receptor signaling pathways
  • Useful for exploring energy‑balance/appetite signaling interactions in cell models
  • Enables evaluation of secretion and metabolic biomarker readouts in vitro

Blend Specification:

  • Cagrilintide 5mg
  • GLP-1S 5mg
SKU: A-14098 Category: Tags: ,
Description

Cagrilintide + GLP-1S (10mg Blend) is a research-use-only peptide blend supplied for controlled laboratory workflows, multi-compound documentation review, and analytical characterization. This blend is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.

Key Product Details

  • Manufactured in accordance with rigorous quality standards to support ≥99% purity, as reflected in batch-specific documentation where available.
  • Every batch is third-party analyzed for identity, assay/potency, and sterility documentation where applicable.
  • Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
  • Produced with lot-level traceability to support research documentation and laboratory recordkeeping.
  • Formulated as a multi-compound research blend containing Cagrilintide and GLP-1S, 10mg total.

Research Documentation Context

  • Supports review of multi-compound blend composition in controlled laboratory settings.
  • Provides batch-specific identity and purity documentation for research review.
  • Allows lot-level traceability across laboratory documentation workflows.
  • Supports comparison of product labeling, analytical documentation, and storage information during research planning.
  • Assists researchers in evaluating component disclosure within a clearly identified peptide blend.

Specifications and Documentation

  • Blend Composition: Cagrilintide + GLP-1S, 10mg total.
  • Certificate of Analysis: Available with batch-specific documentation where applicable.
  • Material Safety Data Sheet: Coming Soon.
  • Handling and Storage Instructions: Coming Soon.
  • Product Form: Lyophilized powder.
  • Purity Specification: ≥99% purity.
  • Intended Use: Laboratory research use only.

Cagrilintide + GLP-1S (10mg Blend) is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.

Additional information
CAS No.

910463-68-2

Purity

≥99%

Sequence

His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly

Molecular Formula

C187H291N45O59

Molecular Weight

4113.64 g/mol

Synthesis

Solid-phase synthesis

Solubility

Soluble in water or 1% acetic acid

Stability & Storage

Stable for up to 24 months at -20°C. After reconstitution

,

may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months.

Applications

Metabolic function research

,

obesity management

,

type 2 diabetes studies

Appearance

White lyophilized powder

Shipping Conditions

Shipped at ambient temperature; once received

,

store at -20°C

Regulatory/Compliance

Manufactured in a facility that adheres to cGMP guidelines

Safety Information

Refer to provided MSDS

Shipping and Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.